Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia
In the present open study the effects of the D1-dopamine antagonist SCH 39166 on positive and negative symptoms of schizophrenia (DSM-IIIR) were investigated. SCH 39166 was given orally according to a fixed dosage schedule (day 1: 25 mg b.i.d; day 4: 50 mg b.i.d.; day 7: 100 mg b.i.d.; day 18: 200 m...
Saved in:
Published in | Psychopharmacology Vol. 121; no. 3; p. 317 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.10.1995
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!